Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

IgG4 immune response in Churg-Strauss syndrome.

Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JH, Schett G, Zwerina J.

Ann Rheum Dis. 2012 Mar;71(3):390-3. doi: 10.1136/ard.2011.155382. Epub 2011 Nov 25.

PMID:
22121132
2.

Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.

Chanseaud Y, Tamby MC, Guilpain P, Reinbolt J, Kambouchner M, Boyer N, Noël LH, Guillevin L, Boissier MC, Mouthon L.

J Autoimmun. 2005 Mar;24(2):169-79.

PMID:
15829409
3.

Analysis of serum IgG subclasses in Churg-Strauss syndrome--the meaning of elevated serum levels of IgG4.

Yamamoto M, Takahashi H, Suzuki C, Tabeya T, Ohara M, Naishiro Y, Yamamoto H, Imai K, Shinomura Y.

Intern Med. 2010;49(14):1365-70. Epub 2010 Jul 15.

4.
5.

Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.

Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, Hellmich B, Csernok E, Distler J, Manger B, Redlich K, Schett G, Zwerina J.

Rheumatology (Oxford). 2008 Jun;47(6):804-8. doi: 10.1093/rheumatology/ken033. Epub 2008 Apr 8.

PMID:
18397958
6.

Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.

Jakiela B, Szczeklik W, Plutecka H, Sokolowska B, Mastalerz L, Sanak M, Bazan-Socha S, Szczeklik A, Musial J.

Rheumatology (Oxford). 2012 Oct;51(10):1887-93. Epub 2012 Jul 5.

PMID:
22772323
7.

IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener's): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases.

Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, Yi ES.

Hum Pathol. 2013 Nov;44(11):2432-7. doi: 10.1016/j.humpath.2013.05.023. Epub 2013 Aug 30.

PMID:
23993777
8.

The common allergens in the Churg-Strauss syndrome.

Bottero P, Bonini M, Vecchio F, Grittini A, Patruno GM, Colombo B, Sinico RA.

Allergy. 2007 Nov;62(11):1288-94.

9.

Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

Terrier B, Bièche I, Maisonobe T, Laurendeau I, Rosenzwajg M, Kahn JE, Diemert MC, Musset L, Vidaud M, Sène D, Costedoat-Chalumeau N, Le Thi-Huong D, Amoura Z, Klatzmann D, Cacoub P, Saadoun D.

Blood. 2010 Nov 25;116(22):4523-31. doi: 10.1182/blood-2010-02-267542. Epub 2010 Aug 20.

10.

What are the characteristics of asthma patients with elevated serum IgG4 levels?

Flament T, Marchand-Adam S, Gatault P, Dupin C, Diot P, Guilleminault L.

Respir Med. 2016 Mar;112:39-44. doi: 10.1016/j.rmed.2016.01.014. Epub 2016 Jan 22.

PMID:
26823212
11.

Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.

Tsurikisawa N, Saito H, Tsuburai T, Oshikata C, Ono E, Mitomi H, Akiyama K.

J Allergy Clin Immunol. 2008 Sep;122(3):610-6. doi: 10.1016/j.jaci.2008.05.040. Epub 2008 Jun 30.

PMID:
18586318
12.

Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome.

Kiene M, Csernok E, Müller A, Metzler C, Trabandt A, Gross WL.

Arthritis Rheum. 2001 Feb;44(2):469-73.

13.

[A case of Churg-Strauss syndrome with elevated IgG4--the association between treatment and IgG4].

Akiyama T, Tashiro K, Yamamoto A.

Rinsho Shinkeigaku. 2013;53(2):131-5. Japanese.

PMID:
23470894
14.

Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.

Saito H, Tsurikisawa N, Tsuburai T, Akiyama K.

Int Arch Allergy Immunol. 2008;146 Suppl 1:73-6. doi: 10.1159/000126065. Epub 2008 May 27.

PMID:
18504411
15.

High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.

Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2009 Apr;68(4):564-7. doi: 10.1136/ard.2008.099051. Epub 2008 Nov 17.

PMID:
19015208
16.

Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.

Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, Oksman F, Lesavre P.

J Rheumatol. 1993 Aug;20(8):1345-9.

PMID:
7901412
17.

The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI).

Mohammad AJ, Bakoush O, Sturfelt G, Segelmark M.

Scand J Rheumatol. 2009;38(4):268-75. doi: 10.1080/03009740802668554.

PMID:
19296401
18.

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.

Kim S, Marigowda G, Oren E, Israel E, Wechsler ME.

J Allergy Clin Immunol. 2010 Jun;125(6):1336-43. doi: 10.1016/j.jaci.2010.03.028.

PMID:
20513524
19.

Churg-Strauss syndrome with a clinical condition similar to IgG4-related kidney disease: a case report.

Ayuzawa N, Ubara Y, Keiichi S, Masayuki Y, Hasegawa E, Hiramatsu E, Hayami N, Suwabe T, Hoshino J, Sawa N, Kawabata M, Ohashi K, Takaichi K.

Intern Med. 2012;51(10):1233-8. Epub 2012 May 15.

20.

Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.

Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, Epplen JT.

Arthritis Rheum. 2008 Jun;58(6):1839-48. doi: 10.1002/art.23496.

Supplemental Content

Support Center